Abstract Previous reports have described panhypopituitarism associated with severe cases of hemorrhagic fever with renal syndrome (HFRS), but the prevalence of hormonal deficiencies after nephropathia epidemica (NE), a milder form of HFRS, has not been studied. This study was conducted in order to determine the prevalence of hormonal defects in patients with acute NE and during long-term follow-up. Fiftyfour patients with serologically confirmed acute NE were examined by serum hormonal measurements during the acute NE, after 3 months, and after 1 to 10 (median 5) years. Thirty out of 54 (56%) patients had abnormalities of the gonadal and/ or thyroid axis during the acute NE. After a median follow-up of 5 years, 9 (17%) patients were diagnosed with a chronic, overt hormonal deficit: hypopituitarism was found in five patients and primary hypothyroidism in five patients. In addition, chronic subclinical testicular failure was found in five men. High creatinine levels and inflammatory markers during NE were associated with the acute central hormone deficiencies, but not with the chronic deficiencies. Hormonal defects are common during acute NE and, surprisingly, many patients develop chronic hormonal deficiencies after NE. The occurrence of long-term hormonal defects cannot be predicted by the severity of acute NE.
Introduction
Nephropathia epidemica (NE) is a form of hemorrhagic fever with renal syndrome (HFRS), caused by Puumala hantavirus (PUUV) [1] . PUUV along with its host, the bank vole (Myodes glareolus), is found all over Europe, excluding the Mediterranean region. In Finland, 1,000-3,000 serologically verified cases occur annually and the average PUUV seroprevalence in the population is 5%. Other hantaviruses causing HFRS include Hantaan (HTNV), Dobrava (DOBV), Saaremaa, and Seoul viruses, while several others found in the Americas cause hantavirus cardiopulmonary syndrome [1] . NE is clinically characterized by fever, headache, nausea, backache, and abdominal pain, as well as transient renal insufficiency [2] [3] [4] . Hemorrhages are rare. Complete recovery from NE is the usual outcome, but a convalescent phase with fatigue may last for months [2] [3] [4] . Genetic susceptibility seems to determine the severity of NE, as individuals with the HLA B8 DRB1*0301 haplotype have been shown to suffer from a severe form of the disease [5] , while the HLA B27 allele correlates with a mild clinical course [6] .
There are case reports of hypophyseal hemorrhage and panhypopituitarism in patients with acute NE [7] [8] [9] [10] [11] .
Postmortem studies of patients with HTNV-induced HFRS, as well as in the few fatal cases of NE, have revealed hemorrhage and necrosis of the pituitary gland in 50-100% of the autopsies [11] [12] [13] . The PUUV antigen has been detected in hypophyseal neuroendocrine and endothelial cells of a patient with fatal NE [8] . In a recent retrospective Serbian study of 60 adults with a previous HFRS, a high prevalence of hypopituitarism was identified after recovery from HFRS [14] . Immunological factors including tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) have been suggested to be involved in the pathogenesis of NE [15] . Cytokines produced in inflammatory foci may also cause changes in the endocrine system, including activation of the hypothalamic-pituitary-adrenal (HPA) axis [16, 17] .
In the present study, we examined the prevalence of hormonal abnormalities in hospital-treated patients with NE, during both the acute illness and long-term follow-up. We also studied whether the hormonal abnormalities associated with NE were related to the clinical severity of the acute illness, the intensity of the cytokine response (plasma IL-6 and TNF-α levels), or the immunogenotype of the patient (HLA-B8, -DR3, and -B27 alleles).
Materials and methods

Subjects
The original patient group consisted of 70 prospectively collected consecutive patients, hospitalized due to serologically verified acute PUUV infection at Tampere University Hospital, Finland, during the years 1997 to 1999. The specific serological diagnosis was based on an immunoglobulin M-capture enzyme immunoassay and PUUV Sotkamo strain full-length N protein expressed by using the baculovirus system in Sf9 insect cells [18] . In comparison with various other protocols, the assay showed optimal sensitivity and specificity [19] . Fifty-four of the patients attended the 12-month follow-up visit, and they comprised the present study population. The median patient age was 42 years (range 15-70 years), and 37 (69%) of them were male. Fourteen patients had previous diseases: hypertension in four patients, hypothyroidism in two, as well as ankylosing spondyloarthritis, bronchial asthma, aortic valve disease, coeliac disease, sequel of renal tuberculosis, operated cancer of the vocal cords, operated meningioma, and osteoporosis in one each. All of the patients continued their regular medications during the study, including two patients with L-thyroxine substitution for hypothyroidism. None of the patients received corticosteroid therapy, or any other drug that could possibly affect plasma hormone concentrations, except for the two patients on L-thyroxine substitution therapy. One female patient was breast-feeding during acute NE and her estradiol (E2), follicle-stimulating hormone (FSH), and prolactin (PRL) values were excluded from the analyses. The Ethics Committee of Tampere University Hospital approved the study and every patient gave a written informed consent to participate.
Study protocol
All of the patients were examined during their hospital stay. Detailed medical histories were obtained, and a careful physical examination was performed. All blood specimens were obtained between 0730-0930 h in the morning. Blood samples for plasma creatinine, C-reactive protein (CRP), IL-6, TNF-α, and blood cell counts, as well as 24-h urinary protein excretion were collected on three consecutive mornings after hospital admission. The first blood sample for hormonal analyses was obtained on the first morning of hospital care, and the second sample was taken on the third morning. The highest or the lowest value of each variable measured during hospitalization was designated as the maximum or the minimum value, respectively. All of the serum samples for hormone analyses were stored at −70°C until their use.
The patients were scheduled to an outpatient examination 3 and 12 months after the acute disease. Forty-nine patients attended the 3-month visit (74 to 146 days, median 102 days after admission), and 54 the 12-month visit. The last prearranged follow-up visit was organized in 2004 (4 to 7 years, median 5 years after NE), and 38 patients participated. All serum hormonal levels were analyzed in 2007. Due to the hormonal results, we invited six patients to an additional visit in 2008 (9 to 10 years, median 10 years after NE), and they underwent physical, laboratory, and imaging studies, as appropriate (see the next section).
Methods
Plasma creatinine and CRP concentration, blood cell counts, and 24-h urinary protein excretion were determined by standard laboratory methods. Plasma IL-6 and TNF-α concentrations were determined using enzyme-linked immunosorbent assays (ELISA; PeliKine Compact™ human IL-6 and TNF-α kits, Red Cross Blood Transfusion Service, Amsterdam, The Netherlands). The analyses of the alleles HLA-B8, -DR3, and -B27 were performed as described elsewhere [20] .
Serum free thyroxine (fT4) and thyrotropin (TSH) were measured by a chemiluminescent microparticle immunoassay (Abbott Architect i2000 system, Abbott Laboratories, IL, USA), cortisol, PRL, luteinizing hormone (LH), and FSH by fluoroimmunoassay (1235 AutoDELFIA, Wallac Ltd., Turku, Finland), and E2 as well as testosterone (Testo) by radioimmunoassay (1277 GammaMaster, Wallac Ltd.). The six patients invited to an additional visit in 2008 were also studied for serum levels of growth hormone (GH) by time-resolved fluoroimmunoassay (AutoDELFIA hGH, Wallac Ltd.), insulin-like growth factor 1 (IGF-1) by immunoluminometric assay (DiaSorin Liaison IGF1, Saluggia, Italy), antibodies against thyroid peroxidase (TPOAb) by immunoluminometric assay (Abbott Architect Anti-TPO, Wiesbaden, Germany), as well as for adrenocortical function by the standard 250-μg ACTH stimulation test.
The reference ranges were 9.0-19.0 pmol/l for fT4, 0.4-4.0 mU/l for TSH, 180-680 nmol/l for cortisol, <450 mU/l for PRL in male patients, <600 mU/l in premenopausal women, and <280 mU/l in postmenopausal women. The male reference ranges were 10.4-34.6 nmol/l for Testo and 0.7-6.7 U/l for LH. As the phase of menstrual cycle was not known, E2 below 0.1 nmol/l was regarded as a hypogonadal value for a premenopausal woman. GH reference range was 0-11.5 mU/l, and the age-specific reference values for IGF-1 were 19-65 nmol/l at 18-20 years, 15-45 nmol/l at 21-30 years, 14-36 nmol/l at 31-50 years, 10-29 nmol/l at 51-70 years, and 8-23 nmol/l over 70 years of age. The TPOAb reference range was <6 U/ml. Cortisol response exceeding 550 nmol/l was considered to be normal in the ACTH test.
Peri-and postmenopausal women were not analyzed for defects of the gonadal axis, as they were hypogonadal by definition. However, their FSH and E2 levels were included in the analysis of hormonal alterations between the acute illness and 3 months afterwards. Chronic, overt hypogonadism was defined as Testo (in men) or E2 (in premenopausal women) repeatedly below the reference range one year or more after the acute NE. Chronic, subclinical/ compensated testicular failure was diagnosed in a male patient with chronically elevated LH but Testo within the reference range. Chronic, overt hypothyroidism was defined as fT4 repeatedly below 9.0 pmol/l and/or TSH repeatedly above 4.0 mU/l in a patient with chronic thyroiditis, goiter, and/or symptoms suggestive of hypothyroidism [21] .
Thyroid ultrasound imaging (Vivid I, GEMS Ultrasound, Tirat Carmel, Israel) was performed by the same investigator (P.J.) on the six patients attending the additional visit in 2008. The hypothalamic-pituitary region was studied by magnetic resonance imaging (MRI; MAGNETOM Trio 3-Tesla scanner, Siemens, Erlangen, Germany) in the patients showing distinct hormonal deficits of central origin.
Statistics
To describe the data, medians (ranges) were given for continuous variables and percentages for categorical variables. Comparisons between the groups were made with the MannWhitney U-test for continuous variables, while Pearson's Chi-square test or Fisher's exact test was used for categorical data. Wilcoxon's signed-rank test was used to evaluate changes in serum hormone levels between the acute phase of NE and 3 months afterwards, and between 3 months and 1 year or 5 years, respectively. Correlations were calculated by means of Spearman's rank correlation coefficient. A p-value of less than 0.05 in two-sided testing was considered to be statistically significant. Statistical analyses were performed using SPSS for Windows version 7.5 (SPSS Inc., Chicago, IL, USA).
Results
Clinical and laboratory findings during acute NE
The clinical picture was typical of acute NE in all patients. All had fever lasting for a median of 5 days (range 2 to 14 days). Ten (19%) received empirical antibiotics, but in none of them could a bacterial infection be confirmed. Acute impairment of renal function (maximum plasma creatinine concentration measured during hospital stay >100 μmol/l) was observed in 78% of the patients, and three needed transient dialysis therapy. Thrombocytopenia (blood platelet count <150×10 9 /l) was present in all patients, but none had major bleeding complications. Hypotension (systolic blood pressure <90 mmHg) was observed on admission in three patients and was corrected by fluid infusion.
Serum hormone levels during the acute phase of NE Table 1 shows that the serum median cortisol and PRL levels were higher and Testo concentrations lower during the acute phase of NE compared to the corresponding values after 3 months. The serum median LH level did not change. There were, however, remarkable individual differences in the direction and magnitude of serum Testo and LH alterations (Fig. 1) . The serum TSH level was slightly higher and FSH concentration lower during the acute phase than after 3 months (Table 1 ). There were no differences between the median hormone levels (cortisol, PRL, fT4, TSH, Testo, LH, E2, and FSH) measured at 3 months compared to the levels measured after 1 or 5 years (data not shown).
The serum cortisol concentration during acute NE correlated positively with the maximum plasma creatinine and IL-6 levels (r=0.352, p=0.009, and r=0.319, p=0.019, respectively), with blood leukocyte count (r=0.370, p= 0.006), and with serum PRL level (r=0.402, p=0.003). Similarly, the serum PRL level correlated with creatinine and IL-6 levels (r=0.511, p<0.001, and r=0.338, p=0.012, respectively), and with blood leukocyte count (r=0.421, p=0.002).
Eighteen out of 37 (49%) men presented with a low Testo level during the acute phase of NE. Fifteen of them had a coincident serum LH level within the reference range, and three had an increased LH level. In addition, 5 (14%) men had an elevated LH concentration together with a Testo level within the reference range. None of the eight male patients with acute primary hypogonadism (elevated LH) complained of testicular pain. The minimum Testo concentration correlated inversely with age and leukocytosis (r=−0.341, p=0.039, and r=−0.493, p=0.002, respectively), and with maximum creatinine, IL-6, CRP, and PRL levels (r=−0.437, p=0.007; r=−0.411, p=0.011; r=−0.352, p=0.032, r=−0.363, p=0.027, respectively), but not with body mass index (BMI) (r=−0.009, p=0.957). Three out of six premenopausal women (aged 16, 21, and 37 years) presented with low E2 and FSH levels during the acute phase of NE (E2 range 0.04-0.05 nmol/l, and FSH range 0.08-0.8 U/l).
Two patients had a low serum fT4 level together with a low-normal TSH level during the acute phase. Five out of Fig. 1 Serum testosterone (A) and luteinizing hormone (LH) (B) levels measured in 37 men during acute nephropathia epidemica (NE) and after 3 months. Testosterone levels were below the reference range in half of the men during acute NE, while LH levels were within the reference range in the majority, indicating that the hypogonadism was mostly of central origin. The reference ranges were 10.4-34.6 nmol/l for testosterone (vertical line showing lower reference limit) and 0.7-6.7 U/ l for LH (vertical line showing higher reference limit) 54 (9%) patients presented with an increased serum TSH level together with fT4 within the low-normal range; one of them had a previously diagnosed primary hypothyroidism, and she used L-thyroxine substitution throughout the study. Serum fT4 and TSH levels measured during acute NE did not correlate with age, BMI, plasma creatinine, CRP, or cytokine levels (data not shown).
Altogether, 30 out of 54 (56%) patients had abnormalities of the gonadal and/or thyroid axis during the acute phase of NE. Central hormonal defects were found in 19 patients, while 13 patients had a primary deficit. As shown in Table 2 , the patients with central hormonal deficiencies had a higher plasma creatinine concentration and blood leukocyte count than the patients with normal hormone levels.
There were no differences in the clinical picture or basic laboratory findings during acute NE between the patients with primary hormonal deficiencies and those with normal hormone levels (data not shown), and neither did the cytokine levels or HLA-B8, -DR3, and -B27 alleles predict the acute primary hormone deficits.
Hormonal deficiencies one to ten years after NE During a median follow-up of 5 years, 9 out of 54 (17%) NE patients presented with chronic, overt hormonal deficits. Table 3 shows the serial plasma hormone levels of these patients. The clinical diagnoses of overt hormonal deficiencies were based both on the hormone measurements and on the clinical signs and symptoms of the patients.
One of the two patients with hormone levels suggestive of combined pituitary hormone defects, a 43-year-old male patient (patient 1, Table 3 ), presented with low testosterone levels and declining fT4 levels within the low reference range during acute NE, as well as after 3 and 12 months (Testo 7.1-7.8-7.6 nmol/l, LH 2.8-2.1-1.8 U/l, fT4 11.9-10.6-10.4 pmol/l, and TSH 2.8-3.8-1.9 mU/l, respectively). He died for an unknown reason soon after his 1-year follow-up visit. The hormone levels, indicating central hypogonadism and possible hypothyroidism, were analyzed only after his death. The overt hormonal deficiencies of the other patients had also gone unnoticed until the patients were invited to the additional visit in 2008. Only one female patient had been started on Lthyroxine, due to overt hypothyroidism diagnosed 9 years after the acute NE (patient 8, Table 3 ).
There were no differences in the age or gender distribution, clinical picture, or basic laboratory findings during acute NE between those nine patients who presented with chronic hormone deficiencies after NE and those with normal hormone levels ( Table 4 ). None of the three patients who were hypotensive on admission developed chronic hormonal deficiencies. The prevalence of HLA-B8, -DR3, and -B27 alleles did not differ between the groups (data not shown).
Imaging studies during the additional visit in 2008
Thyroid ultrasound examination showed diffuse or patchy hypoechogenicity, pertinent with thyroiditis, in the five patients with primary hypothyroidism, while TPOAb were measurable in only two of them. A sellar MRI scan was performed during the additional visit in 2008 in two men whose symptoms and hormone levels suggested central Table 3 ), and the other was a 41-year-old patient who developed a marked secondary hypogonadism and a probable secondary hypothyroidism (patient 2, Table 3 ). The MRI scans showed no pathology of the hypothalamicpituitary region in either of them.
Discussion
To our knowledge, this is the first study on hormonal alterations occurring during and after NE. Serum cortisol and PRL levels were higher and serum Testo concentrations lower during acute NE compared to the corresponding The reference ranges were 10.4-34.6 nmol/l for testosterone and 0.7-6.7 U/l for LH in men. An E2 level below 0.1 nmol/l was considered to be hypogonadal in premenopausal women, as the phase of menstrual cycle was not known. Peri-and postmenopausal women were not analyzed for gonadal defects, as they were hypogonadal by definition. The reference range for fT4 was 9.0-19.0 pmol/l and for TSH, it was 0.4-4.0 mU/l Table 4 Clinical and laboratory findings during the acute phase of NE in the nine patients who developed chronic hormonal defects after NE compared to those in the 45 patients whose hormone levels remained normal during the follow-up The Mann-Whitney U-test was used for continuous variables and Pearson's Chi-square test was used for gender M = male; F = female; IL = interleukin; TNF-α = tumor necrosis factor alpha; min = minimum; max = maximum values after 3 months. These acute hormonal alterations were related to the severity of acute renal insufficiency and inflammation. After one to ten years, surprisingly, many patients suffered from chronic hormonal deficits of either central or peripheral origin. The chronic defects could not be predicted by renal insufficiency, degree of inflammation, or other markers of the clinical severity of acute NE, or by the host genetic factors studied. Approximately half of the men and premenopausal women presented with low serum gonadal hormone levels during the acute phase of NE. Serum Testo levels, in general, increased during a 3-month follow-up, while concomitant LH levels remained stable, indicating that the acute hypogonadism was transient and of central origin in most cases. The degree of hypothalamic-pituitary-gonadal axis suppression, as well as the increase in plasma cortisol production, are known to be related to the severity of acute illness [22, 23] . Also, in our patients with acute NE, low Testo levels and high cortisol and PRL levels were related to the degree of inflammation and the severity of acute renal failure. As the kidneys are involved in the elimination of PRL and corticosteroids [24, 25] , the acute impairment of renal function during NE may have resulted in diminished clearance of PRL and cortisol, contributing to their increased serum levels.
We also found eight male patients with acute primary hypogonadism during PUUV infection. Three out of these eight acute testicular failures developed into chronic, compensated failures, i.e., Testo levels remained within the normal range, while LH levels were chronically elevated. In addition, two cases of chronic, compensated hypogonadism developed during the follow-up, without testicular dysfunction during the acute NE. There are no previous reports of clinical orchitis or primary hypogonadism in hantaviral diseases. However, the possibility remains that PUUV infection may have contributed to the pathogenesis of acute and chronic primary hypogonadism, which were overrepresented [26, 27] in this relatively young group of patients (median age in males 39 years, the youngest patient with chronic hypogonadism 30 years).
Primary hypothyroidism was remarkably frequent in our patients with NE. Two patients had been diagnosed with hypothyroidism prior to NE, and five more diagnoses of primary hypothyroidism were made during the follow-up. The overall prevalence of primary hypothyroidism thus mounted up to 24% in the female patients and 8% in the males, which are about three-fold prevalences compared to those recently reported for similar age groups in the general population [28] [29] [30] . All of the patients diagnosed with primary hypothyroidism in the present study showed a hypoechogenic structure of the thyroid on ultrasound examination, suggesting chronic thyroiditis [31, 32] . TPOAb were present in only two of the five "new" cases of hypothyroidism, which may indicate that in the other three cases, the thyroiditis was not of autoimmune origin, but was possibly induced by the PUUV infection. The primary thyroid, or gonadal, defects did not relate to age, gender, or the degree of renal insufficiency or inflammation during acute NE. A high level of vigilance for possible signs of thyroid or gonadal dysfunction seems warranted in patients with a history of previous NE.
Seventeen percent of the present study patients were diagnosed with a chronic, overt hormonal deficit. In a recent retrospective Serbian study, the prevalence of any endocrine deficiency 2 years after HFRS was 18% [14] . It is noteworthy that the patients in the Serbian study had a more severe HFRS than our patients. In the present study, only three patients needed dialysis treatment, while 57% of the Serbian patients were dialyzed. PUUV and DOBV coexist in the Balkan area, and induce HFRS with significant differences in severity [33, 34] . DOBV-infected patients have more frequently suffered from acute renal failure requiring dialysis treatment, shock, severe thrombocytopenia, and hemorrhagic complications than patients with PUUV [33, 34] . In the present study, chronic hormonal defects could not be predicted by the severity of acute NE. Hence, it is worth noticing that chronic hormonal deficits might occur even after a relatively mild hantaviral infection.
Previous case reports of severe HFRS have described hypophyseal hemorrhage and panhypopituitarism associated with PUUV and HTNV infections [7] [8] [9] [10] [11] [35] [36] [37] [38] . The development of hypophyseal hemorrhage and subsequent panhypopituitarism has varied from acute to subacute. The mechanisms of pituitary hemorrhage are unknown, although hypovolemic shock and thrombocytopenia may contribute to the pathogenesis. In the present patients, thrombocytopenia or hypotension during acute NE did not correlate with either acute-phase or long-term hormonal abnormalities. Neither were there any MRI findings pertinent with previous hypophyseal or hypothalamic hemorrhage in the patients with central hormonal defects. It is likely that the secondary hormone deficiencies found in the present series of NE patients developed by mechanisms other than an acute hemorrhagic disruption of the pituitary.
Headache, vertigo, visual disturbances, and other signs of central nervous system involvement occur frequently in NE [2, 3, 39, 40] , and cases of PUUV-induced meningoencephalitis have been reported [2, 3, 41, 42] . The presence of PUUV RNA in cerebrospinal fluid in a patient with acute NE has been confirmed [43] . It has recently been shown that infections of the central nervous system may cause transient or permanent hypothalamic and/or pituitary dysfunction [44] . Viral meningoencephalitis or hypophysitis may also have contributed to the central hormone defects frequently found in our patients.
An important feature in hantaviral infections is a universally increased capillary permeability, causing tissue edema and hypotension [1] . Immunological factors, including the overproduction of pro-inflammatory cytokines during acute infection, are probably involved in the pathogenesis and might result in immune-mediated damage to the endothelial cells [15] . The endothelial damage and increased vascular permeability may have been involved in the pathogenesis of central and peripheral hormonal defects of the NE patients. A tight interaction between the immune and endocrine systems, mainly through the HPA axis [16, 17] , is also likely to play a central role in the hormonal alterations, at least during acute NE.
Our study has some limitations. First, due to the retrospective nature of the hormonal analyses, we did not have complete data on the possible signs and symptoms related to hormonal alterations during and after NE. This may have resulted in underestimation of the hormonal sequelae of NE, as milder forms of pituitary failure cannot be diagnosed by means of basal hormone levels alone. Stimulatory tests of the GH-IGF-1 axis or the HPA axis could have revealed more subtle hormonal defects, over and above the prevalence of overt hormonal failures reported here. In addition, it would have been valuable to include patients with other viral infections as controls. These limitations, however, should be weighed against the strengths of investigating a prospectively gathered group of consecutive patients both during the acute phase of NE and repeatedly during the longterm follow-up. The findings of the present study give rise to prospective, controlled studies to verify the prevalence of hormonal defects after hantaviral diseases, and to clarify the pathogenesis of these hormonal alterations.
In summary, hormonal alterations were common during acute NE, and the acute hormone deficits of central origin correlated with the clinical severity of NE. Chronic hormonal defects, however, could not be predicted by the severity of acute NE, and chronic deficits emerged even after a relatively mild course of NE. Patients with a history of NE should be readily investigated for hormonal deficiencies, in view of the high prevalence of chronic central and peripheral hormone defects in these patients.
